Follow
Arterra Bioscience S.P.A.
AIM Italia (Italy)
Arterra Bioscience is an Italian biotechnology company with a consolidated "know-how" in molecular biology, cellular and plant biology and extensive experience in the identification of active molecules. By studying the signal transduction mechanisms in plants, animals and human cells, Arterra identifies and characterizes new active compounds with potential industrial applications.
Sector:
HEALTH CARE
>
Biotechnology
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
IT0005386369
AIM Italia
Italy (IT)
Details of share in Arterra Bioscience S.P.A. with ticker
Status
Active
Order book id
Amount of instruments
Par value
Market cap
Currency
EUR
First trading date
Terms
Type
Price
Pre-money valuation
Time
IPO
2.40-3.19 EUR
12M EUR
10 Oct - 18 Oct 2019
IPO in Arterra Bioscience S.P.A.
Market
AIM Italia
Subscription period
10 Oct - 18 Oct 2019
Subscription price range
2.40-3.19 EUR
Subscription final price
Price per share range
2.40-3.19 EUR
Final price per share
Target to raise
5 750 000 EUR
Types
Share issue
Pre-money valuation
12 000 000 EUR
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Upcoming
First trading date
Issue terms
The Global Offer provides for a placement with qualified investors, both Italian and foreign, and an offer to the general public in Italy whose membership can be collected through Directa SIM.
Comments for offer & related information
The pre-money capitalization of the Company will be between € 12 million and € 16 million.
People
Company Details
Sector
HEALTH CARE

Address
Via Benedetto Brin, 69
Zip code
80142
City/district
Napoli
Country
Italy (IT)
Email
Registration number
04593681218
LEI code
8156006E67B9AB95E292
First trade date
Registration date
Short name
Arterra Bioscience
Largest shareholders

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More